Abstract
To determine the anti-complement activity of natural triterpenes, chromatographic separation of the EtOAc-soluble fraction from the fruiting body of Ganoderma lucidum led to the isolation of three steroids and five triterpenoids. They were identified as ergosterol peroxide (1), ergosterol (2), genoderic acid Sz (3), stella sterol (4), ganoderic aic C1 (5), ganoderic acid A (6), methyl ganoderate A (7), and lucidenic acid A (8) based on spectroscopic evidence and physicochemical properties. These compounds were examined for their anti-complement activity against the classical pathway of the complement system. Compounds 2 and 3 showed potent anti-complement activity with IC50 values of 52.0 and 44.6 µM, respectively. Compound 1 exhibited significant inhibitory activity with an IC50 value of 126.8 µM, whereas compounds 4–8 were inactive. Our findings suggested that in addition to the ketone group at C-3, the Δ7(8), Δ9(11)-lanostadiene type triterpene also plays an important role in inhibiting the hemolytic activity of human serum against erythrocytes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arisawa, M., Fujita, A., Gaga, M., Fukumura, H., Hayashi, T., Shimizu, M., and Motita, N., Three new lanostanoids from Ganoderma lucidum. J. Nat. Prod., 49, 621 (1986).
Cheung, W. M., Hui, W. S., Chu, P. W., Chiu, S. W., and Ip, N. Y., Ganoderma extract activates MAP kinases and induces the neuronal differentiation of rat pheochromocytoma PC12 cells. FEBS Lett., 486, 291–296 (2000).
Gao, Y., Zhou, S., Liang, W., and Huang, M., Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol. Invest., 32, 201 (2003).
Hirotani, M., Ino, C., and Furuya, T., Comparative study on the strain-specific triterpenoid components of Ganoderma lucidum. Phytochemistry, 33, 379–382 (1993).
Julia, A. E. and Tony, E. H., Complement factors and their receptors. Immunopharmacology, 38, 3–15 (1997).
Jung, K. Y., Oh, S. R., Park, S. H., Lee, I. S., Ahn, K. S., Lee, J. J., and Lee, H. K., Anti-complement activity of tiliroside from the flower buds of Magnolia forgesii. Biol. Pharm. Bull., 21, 1077–1078 (1998).
Kirschfink, M., Controlling the complement systemin inflammation. Immunopharmacology, 38, 51–62 (1997).
Kubo, M., Matsuda, H., Nogami, M., Arichi, S., and Takahashi, T., Ganoderma lucidum. Effects on disseminated intravascular coagulation. Immunol. Invest., 32, 201–215 (2003).
Kubota, T., Asaka, Y., and Miura, H., Structures of ganoderic acid A and B, two new lanostane type bitter triterpenes from Ganoderma lucidum (Fr.) Karst. Helv. Chim. Acta, 65, 611–619 (1982).
Kuby, J., Complement in immunology 2nd ed., WH freeman company, New York, pp. 336–355, (1994).
Lee, S. M., Park, J. G., Lee, Y. H., Cheal-Gyu Lee C. G., Min, B. S., Kim, J. H., and Lee, H. K. Anti-complementary activity of triterpenoides from fruits of Zizyphus jujube. Biol. Pharm. Bull., 27, 1883–1886 (2004).
Lin, Z. B. and Zhou, J. H., Recent Advances in Chinese Herbal Drugs-Actions and Uses, Scientific Publishing House, pp. 133–140, (1991).
Min, B. S., Gao, J. J., Hattori, M., Lee, H. K., and Kim, Y. H., Anticomplement activity of terpenoids from the spores of Ganoderma lucidum. Planta Med., 67, 811–814 (2001).
Min, B. S., Lee, I., Chang, M. J., Yoo, J. K., Na, M., Hung, T. M., Thuong, P. T., Lee J., Kim J. H., Kim, J. C., Woo, M. H., Choi, J. S., Lee, H. K., and Bae, K., Anticomplementary activity of triterpenoids from the whole plant of Aceriphyllum rossii against the classical pathway. Planta Med., 74, 726–729 (2008).
Min, B. S., Lee, S. Y., Kim, J. H., Lee, J. K., Kim, T. J., Kim, D.H., Kim, Y. H., Joung, H., Lee, H. K., Nakamura, N., Miyashiro, H., and Hattori, M., Anti-complement Activity of Constituents from the Stem-Bark of Juglans mandshurica. Biol. Pharm. Bull., 26, 1042–1044 (2003).
Oh, S. R., Jung, K. Y., Son, K. H., Park, S. H., Lee, I. S., Ahn, K. S., and Lee, H. K., In vitro anticomplementary activity of hederagenin saponins isolated from roots of Dipsacus asper. Arch. Pharm. Res., 22, 317–319 (1999).
Thuong, P. T., Min, B. S., Jin, W. Y., Na, M., Lee, J., Seong, R., Lee, Y. M., Song, K. S., Seong, Y. H., Lee, H. K., Bae, K., and Kang, S. S. Anti-complementary activity of ursane-type triterpenoids from Weigela subsessilis. Biol. Pharm. Bull., 29, 830–833 (2006).
Tohru, K., Satoko, K., Shigetoshi, K., Yoshihiro, M., Koji, T., and Zen-Ichi, O., Consist of the fungus Ganoderma lucidum (Fr.) Karst. structure of ganoderic acids C2, E, I, and K, lucidenic acid F and related compound. Chem. Pharm. Bull., 34, 3695–3712 (1986).
Wang, S. Y., Hsu, M. L., and Hsu, H. C., The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int. J. Cancer, 70, 699–705 (1997).
Wasser, S. P. and Weis, A. L., Medicinal properties of substances occurring in higher Basidiomycete mushrooms: current perspective (review). Int. J. Med. Mush., 1, 31–62 (1999).
Yang, F. C., Ke, Y. F., and Kuo, S. S., Effect of fatty acids on the mycelial growth and polysaccharide formation by Ganoderma lucidum in shake flask cultures. Enzyme Microb. Technol., 27, 295–301 (2000).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seo, H.W., Hung, T.M., Na, M. et al. Steroids and triterpenes from the fruit bodies of Ganoderma lucidum and their anti-complement activity. Arch. Pharm. Res. 32, 1573–1579 (2009). https://doi.org/10.1007/s12272-009-2109-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-009-2109-x